Delivery Order SPE2DB20D3104-SPE2DB22FV7V3
Award Date
6/29/22
Potential Completion Date
6/30/22
Potential Value
$1.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Clindamycin PH 1% Gel, a prescription medication, with a ceiling value of $1,029.48 and a period of performance through May 19, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,132.42 firm fixed-price contract is for the delivery of 4567445128 CLINDAMYCIN 900 MG/50 ML-D5W 50ML, with a completion date of March 4, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The $2,032.48 firm fixed-price contract is for the delivery of Clindamycin 600 mg/50 ml-D5W 50 ml, a medical product used in healthcare settings. The contract has an ultimate completion date of December 19, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,888.43 firm fixed-price contract is for the supply of Clindamycin Phosphate 1% gel, a topical antibiotic medication. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA's Troop Support Medical division, valued at $999,999,999 and running through November 2026. The IDC serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,048.20, is a Delivery Order for the supply of CLINDAMYCIN 600 MG/50 ML-D5W 50ML, a pharmaceutical product, with a performance period through December 31, 2024. AmerisourceBergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award is for the delivery of Clindamycin PH 1% Gel in 30 gram quantities to the Defense Logistics Agency (DLA). The $2,326.73 firm-fixed-price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a delivery order issued under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which has a potential value of up to $999,999,999.00 and runs through November 2026. The...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,349.84 firm fixed-price delivery order (SPE2DB20D1109|SPE2DB24FP90Y) is for the supply of Clindamycin Phosphate 1% Gel, a topical antibiotic medication. The contract has an ultimate completion date of September 17, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Clindamycin 900 mg/50 ml-D5W 50 ml. The order has a ceiling value of $1,253.68 and a completion date of September 23, 2024. This is not a set-aside contract. AmerisourceBergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for delivering a wide range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The contract, valued at $1,226.44, is for the supply of Clindamycin 60ml medical products. The contract has a period of performance through September 11, 2024 and is a firm-fixed price contract. Amerisourcebergen is a major pharmaceutical and medical supply distributor that holds several Indefinite Delivery Contracts (IDCs) with federal...
This federal contract award, valued at $1,812.42, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Clindamycin PH 1% Gel, a topical antibiotic medication, with a period of performance through October 2024. The contract is not designated under any set-aside program, indicating open competition. Amerisourcebergen Drug Corp is a for-profit...